Integrated Methods to Discover Novel Disease Pathways

Information

  • Research Project
  • 6870065
  • ApplicationId
    6870065
  • Core Project Number
    R44AG022242
  • Full Project Number
    4R44AG022242-02
  • Serial Number
    22242
  • FOA Number
    PA-00-18
  • Sub Project Id
  • Project Start Date
    8/1/2003 - 20 years ago
  • Project End Date
    9/30/2004 - 19 years ago
  • Program Officer Name
    SIERRA, FELIPE
  • Budget Start Date
    6/15/2004 - 20 years ago
  • Budget End Date
    9/30/2004 - 19 years ago
  • Fiscal Year
    2004
  • Support Year
    2
  • Suffix
  • Award Notice Date
    6/14/2004 - 20 years ago

Integrated Methods to Discover Novel Disease Pathways

DESCRIPTION (provided by applicant): Our goal is to accelerate the rate of discovery of novel therapeutic agents by rapidly assigning function to genes with no experimental functional data (NEFD) and organizing them within Protein Interaction Network (PIN) maps. This will facilitate the identification of novel candidate drug targets in disease-associated pathways, such as osteoporosis and Alzheimer's Disease. To begin with, we have mined the public domain and identified a sub-set of NEFD genes (1241) to populate a prototype knowledge database. The design of the database is based on a generic data model with a web based user interface. The aim is to build an Integrated Knowledge Workbench (IKW) in which all data, determined in silico and experimentally, will be incorporated. To transition the prototype to the IKW, we will integrate a suite of bioinformatics analysis tools that will be used to generate detailed in silico fingerprints for every NEFD gene. Furthermore, in Phase I we will integrate protein interaction data derived from our yeast two-hybrid experimental platform. Results from these analyses will be incorporated systematically into the knowledge-based component of the database. To test the platform we will randomly select 5 NEFD genes, generate in silico fingerprints and identify their protein interactors. These data will be integrated to assign a function and produce PIN maps that will chart each of the NEFD genes in a pathway. This test of the system will illustrate the utility of the integrated platform to obtain pertinent information about genes of unknown function and will begin to assist in the determination of their potential role in osteoporosis and Alzheimer's disease-associated pathways.

IC Name
NATIONAL INSTITUTE ON AGING
  • Activity
    R44
  • Administering IC
    AG
  • Application Type
    4
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    474283
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    866
  • Ed Inst. Type
  • Funding ICs
    NIA:474283\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    OSCIENT PHARMACEUTICALS CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    WALTHAM
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    024538443
  • Organization District
    UNITED STATES